An open letter: Farewell 2017, you've been good to us!!22 December 2017Author :Mina Bekheet

Since the founding of Panacea Innovation, we have been privileged to interact with the best minds in Oxford, Cambridge, London and beyond. From academia, industry, finance, legal services, and, crucially to us, the sci-entrepreneurs; our partners and collaborators have aced it. The support and feedback we have received were beyond what one would expect, and we continue valuing this as our most significant asset. We know that innovation is not a zero-sum game, and we believe that it’s neither a Nash equilibrium one. Therefore, we continue our efforts to build solutions aligning with your needs, while maintaining focus on our mission; maximising deep science translation into truly breakthrough products. And now, after a few busy months in preparation, we are taking things a step further.

To this end, we are pleased to announce that, as of today, BioStars is accompanied by two new sister streams, AIStars (Artificial Intelligence) and TEMStars (Technology, Engineering and Mathematics); all under the PanaceaStars umbrella. These new streams enable us to share our passion and rich package of resources across a wider sector of scientists and entrepreneurs. We hope by doing so to pave the way for scientists with the next generation of world-changing moonshot projects to succeed. The application call for our Accelerator programme across all three streams is now open.

To support these programmes, Panaceastars is introducing a new and more inclusive package to sci-entrepreneurs, academic institutes, industrial enterprises and the investment community. We are thrilled to announce the launch of Panacea Ventures, Panacea Innovation’s early-stage investment arm. Panacea Ventures comprises a group of handpicked public, private and corporate investors and seasoned senior executives who constitute the investment body of one or more of Panacea Ventures investment vehicles. This structure is tailor-made to provide more early stage smart capital to companies, opening the door for more early-stage investors to feel comfortable partaking in deep science startups, whilst optimising deal flow and reducing the risk for the wider corporate and investment communities.

We are also launching the first of our Innovation Centers in Oxford on the 15th January 2018, a co-working lab and office space that will provide the necessary infrastructure for our startups. In doing this, we hope to provide more than just physical space, but also a thriving environment that brings the best-in-class scientific and business expertise to the doorstep of our founders.

Moreover, we are expanding our operations internationally via our new “Mini-accelerators” scheme, whereby we expand our activities beyond the UK via a series of overseas workshops.  The best international deep science talent will be invited to join us here in the UK to take advantage of the world-class facilities and expertise on offer.

Such developments would not have been made possible if not for the tremendous support of our government, academic, legal and investment partners, whose continuing faith in our drive to deliver only strengthens our sense of purpose. Over the course of the coming weeks, we will be revealing more information about our new partnerships, with further details on these developments now available on our new PanaceaStars beta online portal.

This is just the beginning; we continue our journey through the learning curve and continue to strive for improvement. We do hope that you are excited by our recent developments and that you will join us in our exciting journey! 

We wanted to say a heartfelt thank you to each and every one of you for the great support, and we wanted to wish you all a very Happy Christmas and a festive break!

On behalf of Panacea Innovation Team,

Mina Bekheet

Founder and Chairman

entrepreneurship investment seed science incubation panacea
WE ARE THE GLOBE’S EARLY STAGE DEEP SCIENCE TRANSLATION AND INVESTMENT HOME. We work with the world’s best minds to kickstart and grow ideas into products that address real humankind needs via novel science and technology. We provide the complete toolkit of early stage investment, R&D, business support, mentorship, incubation and top-notch industry partnerships.